Publications
2 shownMulti-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
Purpose: To evaluate the efficacy and tolerability of two doses of gefitinib (Iressa [ZD1839]; AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor tyrosine ki...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 3
- Citations
- 8,733
- Institution
- Universitair Ziekenhuis Leuven
External Links
Identifiers
- ORCID
- 0000-0002-3368-0386
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.